Publishers' Views on PRISM | GenomeWeb

Alex Palazzo on The Daily Transcript posted some publishers' reactions to PRISM's anti-open access stance -- they don't like it. Rockefeller's Mike Rossner asked for a disclaimer on PRISM's website and outlined five major reasons he did not agree with PRISM.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.